RedHill Biopharma Ltd.


RedHill Biopharma Says First Coronavirus Patient Treated With Opaganib Drug

RedHill Biopharma Ltd. (RDHL) said on Monday that its first coronavirus patient has been treated with with the company’s new proprietary drug called …

Roth Capital Highlights RedHill As A Company To Watch In 2015; Raises PT To $27.50

In a research report issued today, Roth Capital analyst Scott Henry reiterated a Buy rating on RedHill Biopharma (NASDAQ:RDHL) and raised his price …

We Are Looking For An Eventful 2015 For RedHill Biopharma, Says MLV

MLV analyst Vernon Bernardino is out with a research report on RedHill Biopharma (NASDAQ:RDHL), reiterating a Buy rating and a $25 price target, which represents a potential …

MLV Cuts RedHill Price Target To Reflect A Delay In Rizaport Approval

In a research report issued today, MLV analyst Vernon Bernardino reiterated a Buy rating on RedHill Biopharma (NASDAQ:RDHL) but slightly reduced his price target …

RedHill’s Enterprise Value Of ~$100 Million Underestimates The Breadth Of Its Pipeline, Says Roth Capital

In a research report issued today, Roth Capital analyst Scott Henry maintained a Buy rating on RedHill Biopharma (NASDAQ:RDHL), with a price target of …

Roth Capital Maintains Buy On RedHill, Boosts Price Target To $24

In a research note issued this morning, Roth Capital analyst Scott Henry maintained a Buy rating on RedHill Biopharma (RDHL) and raised his price target …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts